key: cord-0721604-jgplpb1z authors: Otmani Idrissi, Myriem; Baudoin, Jean-Pierre; Chateau, Anne-Line; Aherfi, Sarah; Bedotto-Buffet, Marielle; Latil, Alain; Lepidi, Hubert; Chiaroni, Jacques; Picard, Christophe; Mege, Jean-Louis; La Scola, Bernard; Mezouar, Soraya title: Presence of SARS-CoV-2 in a Cornea Transplant date: 2021-07-24 journal: Pathogens DOI: 10.3390/pathogens10080934 sha: 2889f481365c6154676ff3d77d5726fd4a61f13e doc_id: 721604 cord_uid: jgplpb1z Background: The SARS-CoV-2 pandemic has impacted tissue transplantation procedures since conjunctivas were found to be associated with coronavirus infection. Here, we investigated infection of a cornea graft from a COVID-19-positive donor. Methods: In order to evaluate the presence of SARS-CoV-2 in the cornea graft we first carried out a qRT-PCR and then we investigated the presence of SARS-CoV-2 by fluorescence and electron microscopy. Conclusions: Although the cornea graft was found to be negative by qRT-PCR, we were able to show the presence of SARS-CoV-2 in corneal cells expressing the SARS-CoV-2 receptor, ACE2. Taken together, our findings may have important implications for the use of corneal tissue in graft indications and open the debate on SARS-CoV-2 transmissibility. The SARS-CoV-2 pandemic has radically impacted ophthalmology practices, particularly tissue transplantation procedures, as conjunctivas have been identified to be associated with coronavirus infection [1] . Although no SARS-CoV-2 has been detected via qRT-PCR in ocular tissue, some rare cases of conjunctivitis were reported with positive SARS-CoV-2 qRT-PCR results from conjunctival secretions and tears [1] . Moreover, SARS-CoV-2 infection of macaques was reported through the conjunctival pathway [2] , suggesting that SARS-CoV-2 used the conjunctival route of transmission. Finally, the expression of angiotensin-converting enzyme-2 (ACE2) was found on corneal and conjunctival cells [3] , suggesting that the cornea could be a target tissue for SARS-CoV-2 infection. The nucleocapsid protein antigen of SARS-CoV-2 was found intracellularly in the ocular tissues of a patient without ocular signs two months after infection [4] . Here, we hypothesize that without ocular clinical signs, SARS-CoV-2 may be present in corneal grafts. We report a case of corneas collected postmortem from a SARS-CoV-2-positive donor that had no signs of eye disease, such as conjunctivitis. The donor, an 88-year-old woman with no known infection history of SARS-CoV-2, was admitted to the hospital for abdominal pain in the context of colon cancer. The patient had no evidence of upper respiratory infection, and a qRT-PCR investigation of nasopharyngeal samples performed at the admission of the patient was negative. The patient died two days later, following the evolution of carcinoma. In accordance with the French regulations for tissue donation (Agence de Biomedecine), a new postmortem RT-PCR test on nasopharyngeal samples, serology (IgG-IgM antibodies, BIOSYNEX, Brant, France) and total antibody tests (ECLIA Cobas, Roche Technologies, Boulogne Billancourt, France) were performed with a positivity for SARS-CoV-2. qRT-PCR investigation on both media containing the corneal grafts and corneal tissues was negative for SARS-CoV-2. Histological examination of corneal grafts showed no lesions, inflammation or tissue damage (epithelium, stroma, endothelium) ( Figure 1a ). These results, from tests traditionally performed in routine clinical practice, did not show the presence of SARS-CoV-2 in corneal tissue from COVID-19-positive organ donors. Regardless of the negative qRT-PCR, we sought to determine whether there was SARS-CoV-2 within the tissue. As histopathological evaluation of positive COVID-19 patients was crucial [5] , we turned to electron microscopy since it has been reported to have some utility in identifying viral particles. We observed numerous virus-like particles localized to large vacuoles in the two corneal grafts (Figure 1b) . SARS-CoV-2-like particles were pleomorphic with or without peripheral corona fibers, with a mean diameter of 56 ± 10 nm ( Figure 1b ). Although no conjunctivas and no tissue damage were reported, searching for other viruses involved in keratitis/conjunctivitis appeared pertinent [6] . Testing for herpes simplex virus, cytomegalovirus, enterovirus and adenovirus was negative. We conducted immunofluorescence staining and confirmed the presence of SARS-CoV-2 in corneal grafts (Figure 1c ). At the apical part of the cornea consisting of epithelial cells, we observed the presence of SARS-CoV-2 in corneal cells expressing ACE2 compared to corneal grafts from postmortem donors devoid of SARS-CoV-2 infection. Taken together, this study depends on the use of PCR on the donor tissue to test for the qualification of corneal grafts and the risk of transmission. No lesion or inflammation was observed, suggesting a quiescent state of the virus in the corneal cells, as observed for other types of viruses [6] . Although no studies have reported posttransplant COVID-19 infection thus far, positive SARS-CoV-2 RNA from ocular tissues has been reported to be associated with conjunctivitis [7] . In these conditions, and in the absence of viricidal activity in culture media, the European Centre for Disease Prevention and Control recommends using at least one exposure of ocular tissue to a biocidal agent in their donor protocol. The emergence of studies illustrating the presence of SARS-CoV-2 in corneas should be considered in the regulation of tissue transplantation guidelines, even if this option remains debated [8, 9] . Finally, clinical evaluation of patients has been deeply changed during the COVID-19 pandemic [10, 11] . Here, we reported that the cornea can be infected by SARS-CoV-2. This case, with direct observation of the virus, and another with viral protein detection, suggests infection in the cornea, isolated from acute symptomatic SARS-CoV-2 infection. Taken together, our findings may have important implications for the validation and the use of tissue corneal grafts, opening the debate on SARS-CoV-2 transmissibility. Corneal tissues were obtained from one healthy donor and one postmortem donor reported as carrying SARS-CoV-2 and preserved in Cornea Max medium (Eurobio, Les Ulis, France). Viral RNA was extracted from tissue using a NucleoSpin ® kit (Macherey-Nagel, Hoerdt, France) and SARS-CoV-2 detection was evaluated by qRT-PCR using a SuperScript TM III PlatinumTM Kit (Life Technologies, Carlsbad, CA, USA). Thermal cycling was achieved at 55 • C for 10 min for reverse transcription, followed by 95 • C for 3 min and then 45 cycles at 95 • C for 15 s and 58 • C for 30 s using a LightCycler-480 system (Roche, Meylan, France). We investigated the E and N genes for the detection of SARS-CoV-2 as previously described [12] . Primers and probes were designed against the E (forward: ACAGGTACGT-TAATAGTTAATAGCG, reverse: ATATTGCAGCAGTACGCACACA, probes: FAM-ACAC TAGCCATCCTTACTGCGCTTCG-QSY) and N (forward: GACCCCAAAATCAGCGAAAT, reverse: TCTGGTTACTGCCAGTTGAATCTG, probes: FAM-ACCCCGCATTACGTTTGGT GGACC-QSY) genes. RT-PCR was performed for the detection of adenovirus, enterovirus, cytomegalovirus and herpes simplex virus as previously described [13] [14] [15] [16] . Corneal tissues (5 µM sections) were labeled using hematoxylin-eosin-saffron coloration and observed using an optical microscope. For immunostaining, slides were incubated in a saturation solution containing 3% bovine serum albumin (Eurobio, #5154-0006) and 0.1% Tween-20 (Sigma-Aldrich, #P9416, Saint-Quentin-Fallavier, France) diluted in phosphate-buffered saline (Life Technologies, Gibco, #14190144). The slides were incubated with anti-ACE2 (1:500, antibodies-online, #AA-599-649) and anti-SARS-CoV-2 spike protein (1:500, Thermo Fisher, #PA581795, Carlsbad, CA, USA) and nuclei were counterstained with 4 ,6-diamidino-2-phenylindole (Invitrogen, #D1306, Carlsbad, CA, USA). Next, the sections were incubated with goat anti-rabbit (Thermo Fisher, #A11010) and donkey anti-mouse IgG secondary antibodies (Thermo Fisher, #A11003). Secondary antibodies alone were used for the detection of nonspecific background. After washing, sections were analyzed using an LSM800 Airyscan confocal microscope (Zeiss, 63×, Jena, Germany). Cornea tissues were fixed with glutaraldehyde 2.5% (Biovalley, #16210, Nanterre, France). Resin embedding was microwave-assisted with a BiowavePro + (Pelco, Roseville, CA, USA). Samples were washed with a 0.2 M saccharose (Sigma-Aldrich, #1076870250)/ 0.1 M sodium cacodylate (Sigma-Aldrich, #70114) buffer and postfixed with 1% OsO4 (Sigma-Aldrich, #201030) diluted in 0.2 M potassium hexa-cyanoferrate (III) (Sigma-Aldrich, #P8131)/0.1 M sodium cacodylate buffer. After washes with distilled water, samples were gradually dehydrated by successive 50%, 70% and 96% ethanol baths. Substitution with hard grade LR-White resin (Polysciences, Sigma-Aldrich, #94188-59-7) was achieved by incubations with a mixture of 100% LR-White resin and 96% ethanol in a 2:1 ratio, incubations with 100% LR-White resin and completed with samples in 100% LR-White resin overnight under vacuum. Resin heat curing was achieved by polymerization for 72 h at 60 • C. Ultrathin 70 nm sections were cut using a UC7 ultramicrotome (Leica, Edinburgh, UK) and placed on HR25-300 mesh copper/rhodium grids (TAAB, Berks, UK). Sections were contrasted according to Reynolds 20 . Pictures were obtained on a Morganii 268D (Philips, Salina, CA, USA) transmission electron microscope operated at 80 keV and equipped with a MegaView3 camera. In accordance with the French regulations for tissue donation (Agence de Biomedecine, France), deceased person is presumed consent for organ donation for anatomical study or research. The data presented in this study are available on request from the corresponding author. The data are not publicly available due to ethical restrictions. Absence of Severe Acute Respiratory Syndrome-Coronavirus-2 RNA in ocular tissues Ocular conjunctival inoculation of SARS-CoV-2 can cause mild COVID-19 in rhesus macaques Expression of the COVID-19 receptor ACE2 in the human conjunctiva Severe Acute Respiratory Syndrome Coronavirus 2 Nucleocapsid Protein in the Ocular Tissues of a Patient Previously Infected with Coronavirus Disease Histopathological observations in COVID-19: A systematic review Adenovirus: Ocular manifestations Prevalence of SARS-CoV-2 in human post-mortem ocular tissues Corneal transplantation during COVID-19 pandemic: Need for special considerations-A live review Risks Posed to Corneal Transplant Recipients by COVID-19-Affected Donors COVID-19 risk contagion: Organization and procedures in a South Italy geriatric oncology ward Telephonic triage before surgical ward admission and telemedicine during COVID-19 outbreak in Italy. Effective and easy procedures to reduce in-hospital positivity Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT-qPCR primer-probe sets Pring-Åkerblom, P. Rapid and quantitative detection of human adenovirus DNA by real-time PCR A Retrospective Overview of Enterovirus Infection Diagnosis and Molecular Epidemiology in the Public Hospitals of Marseille Quantification of Human Cytomegalovirus DNA in Bone Marrow Transplant Recipients by Real-Time PCR Detection of Herpes Simplex Virus DNA by Real-Time PCR Acknowledgments: Soraya Mezouar was first supported by the "Fondation pour la Recherche Médicale" postdoctoral fellowship (reference: SPF20151234951) and then by the "Fondation Méditerranée Infection". We thank Asma Boumaza and Issem Hasni for their assistance in this study. The authors declare that they have no competing interest.